14.55 | 11.55 – Panel Discussion: Starting With the End in Mind, Industry Collaboration for Industry Standards
Time: 2:55 pm
day: Day Two
Details:
- How can the industry better work together to unpick and target tumor heterogeneity?
- What can we learn from past successful Drug-Dx collaborations?
- Collaborations and partnering to support regulatory submission pathways
